Details of the Drug

General Information of Drug (ID: DMU980N)

• Drug Name: Agalsidase beta

Indication

Disease Entry	ICD 11	Status	REF
Fabry disease	5C56.01	Approved	[1]

• Affected Organisms: Humans and other mammals
• ATC Code:
  A16AB04: Agalsidase beta
  A16AB: Enzymes
  A16A: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
  A16: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
  A: ALIMENTARY TRACT AND METABOLISM
• Sequence:
  >DB00103 sequence
  LDNGLARTPTMGWLHWERFMCNLDCQEEPDSCISEKLFMEMAELMVSEGWKDAGYEYLCI
  DDCWMAPQRDSEGRLQADPQRFPHGIRQLANYVHSKGLKLGIYADVGNKTCAGFPGSFGY
  YDIDAQTFADWGVDLLKFDGCYCDSLENLADGYKHMSLALNRTGRSIVYSCEWPLYMWPF
  QKPNYTEIRQYCNHWRNFADIDDSWKSIKSILDWTSFNQERIVDVAGPGGWNDPDMLVIG
  NFGLSWNQQVTQMALWAIMAAPLFMSNDLRHISPQAKALLQDKDVIAINQDPLGKQGYQL
  RQGDNFEVWERPLSGLAWAVAMINRQEIGGPRSYTIAVASLGKGVACNPACFITQLLPVK
  RKLGFYEWTSRLRSHINPTGTVLLQLENTMQMSLKDLL
• Cross-matching ID:
  PubChem CID: 52918379
  UNII: RZD65TSM9U
  DrugBank ID: DB00103
  TTD ID: D00FIX

References

• [1] Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015